Infectious diseases

You are here

The publication evaluates the performance and acceptability of first-void urine as specimen for the detection of HPV DNA in a Belgian referral population.
The publication reviews urinary biomarkers for cervical cancer and triage of high-risk human papillomavirus infections.
This publication compares the sensitivity of high risk HPV in self-collected urine samples in the morning , and later on, brush-based self-samples, and clinician-taken smears for detecting of cervical intraepithelial neoplasia grade 2+(CIN2+) in a colposcopic referral population.
The publication estimates the performance of a urine sampling protocol against paired cervical cytological samples, using two HPV assays of differing sensitivity, namely GP5+/6+RLB, an assay developed for clinical specificity in HPV-based cervical screening and E7-MPG, which has greater analytical...
The poster tests the feasibility of testing first-void urine specimens with the Hologic Aptima HPV assay.
The poster assesses the compatibility of the Seegene Anyplex™ II HPV HR test for testing first-void urine specimens.
The poster determines if the Roche COBAS ® (4800) HPV Assay is compatible with Colli-Pee ® collected, UCM preserved urine.
The poster demonstrates feasibility on the use of the GeneXpert HPV Assay with Colli-Pee® collected, UCM preserved urine.
The poster demonstrates feasibility on the use of the GeneXpert HPV Assay with Colli-Pee ® collected, UCM preserved urine.
The poster assesses the acceptance of using first-void urine (FVU) self-sampling as a monitoring tool in vaccinated and unvaccinated women
The poster evaluates a prototype of a new first-void urine collection device (Colli Pee ® ) compared to urine collection vials (Multi-Collect TM , Abbott).
The publication assesses the feasibility of first-void urine as a sample type to measure the impact of vaccination against Human Papilloma Virus (HPV) in Rwanda and Bhutan.

Pages